1,3-Dihydroxyacridone derivatives as inhibitors of herpes virus replication
- 1 February 2000
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 45 (2) , 123-134
- https://doi.org/10.1016/s0166-3542(00)00068-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Resistance of Human Cytomegalovirus to Antiviral DrugsClinical Microbiology Reviews, 1999
- Catalytic inhibitors of DNA topoisomerase IIBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Capsid assembly and DNA packaging in herpes simplex virusReviews in Medical Virology, 1997
- Cellular factors as alternative targets for inhibition of HIV-1Antiviral Research, 1997
- Topoisomerase Poisons: Harnessing the Dark Side of Enzyme MechanismJournal of Biological Chemistry, 1995
- Antiproliferative actions of 7-substituted 1,3-dihydroxyacridones; possible involvement of DNA topoisomerase II and protein kinase C as biochemical targetsBioorganic & Medicinal Chemistry, 1994
- Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: A new strategy for the treatment of human cytomegalovirus infectionAntiviral Research, 1992
- Synthesis of dihydrofolate reductase and metabolism of related RNA in a methotrexate resistant human cell line infected with herpes simplex virus type 2Virology, 1986
- Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolinAntimicrobial Agents and Chemotherapy, 1983
- A synthesis of acronycineAustralian Journal of Chemistry, 1970